Kathlene Balisy

J.R. Simplot Co. engages in the provision of food and agribusiness services. It offers food, agriculture supply, turf and horticulture, livestock, feed ingredient, and industrial products. The firm develops Innate technology, a biotechnology platform for improving crops; and SimVitro, a branded platform for improving genetics and reproductive efficiency in dairy and beef cattle. The company was founded by John Richard Simplot in 1929 and is headquartered in Boise, ID.

Part of SoftBank Group Corp., Ziff Davis Publishing, Inc. publishes technology-based digital content products. The company is based in New York, NY. Ziff Davis Publishing was acquired by SoftBank Group Corp. on October 01, 1994 for $198.91 million.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

MDA is the nonprofit health agency dedicated to curing muscular dystrophy, ALS and related diseases by funding worldwide research. The Association also provides comprehensive health care and support services, advocacy and education. MDA combats neuromuscular diseases through programs of worldwide research, comprehensive medical and support services, and far-reaching professional and public health education. With national headquarters in Tucson, MDA has more than 200 offices across the country, sponsors some 200 hospital-affiliated clinics and supports more than 330 research projects around the world. MDA supports more research on neuromuscular diseases than any other private-sector organization in the world. MDA scientists are in the forefront of gene therapy research and have uncovered the genetic defects responsible for several forms of muscular dystrophy, Charcot-Marie-Tooth disease, a form of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease), childhood spinal muscular atrophy and several other neuromuscular conditions. The Association's comprehensive services program includes diagnostic and follow-up medical consultations, flu shots, support groups, MDA summer camps for youngsters, a medical equipment program, assistance with equipment repairs and resource referral. Through its national advocacy program, MDA works to make life better for people with muscular dystrophy and related muscle diseases by providing representation in matters of public policy and research advancement, nationally and internationally; and facilitating active involvement in these areas by the people it serves. MDA was created in 1950 by a group of adults with muscular dystrophy, parents of children with muscular dystrophy and a physician-scientist studying the disorder. Since its earliest days, it has been energized by its number-one volunteer and national chairman, entertainer Jerry Lewis.

FMR LLC engages in the provision of financial and investment services. It offers financial planning and advice, wealth management, retirement plans, trading and brokerage services, and investment products. The company was founded by Edward C. Johnson II in 1946 and is headquartered in Boston, MA.

Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.

OUP Management Co. LLC (Osage Partners) is a venture capital firm founded in 1990 by Robert Adelson and Louis Berneman. The firm is headquartered in Bala Cynwyd, Pennsylvania.

CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA.

St. Christopher's Hospital for Children LLC provides pediatric, children care services, family advisory council, nurturing and culturally diverse environment. Its services include anesthesiology, audiology, cardiology, and center for the urban child, child life program, child protection program, critical care, dental medicine, developmental pediatrics, ear nose throat, emergency, hepatology nutrition and genetics. The company was founded by William H. Bennett on November 30, 1875 and is headquartered in Philadelphia, PA.

Part of Ziff Davis, Inc., PC Magazine operates an online platform that provides lab-based comparative reviews of computing, consumer electronics, business technology, and internet products. The company is based in New York, NY.

IDG Communications, Inc. operates as a media, data and marketing services company. The firm solutions include media, data, marketing services, events, global partner solutions, and direct marketing. The company is headquartered in Framingham, MA.

SightLine Health LLC engages in the provision of non-invasive treatment options for cancer. It specializes in groundbreaking cancer treatments such as intensity-modulated radiation therapy, image-guided radiation therapy, high-dose-rate brachytherapy, and electron-beam radiation therapy. The company was founded by TJ Farnsworth in 2005 and is headquartered in Corona Del Mar, CA.

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.

ActivePDF, Inc develops PDF server-based tools. It solutions include accounts payable, banking, education, financial, government, healthcare, insurance, and legal. The company was founded by Tim Sullivan in January 2000 and is headquartered in Laguna Niguel, CA.

The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA.

Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA.

Inception Fertility Ventures LLC operates fertility clinics. It offers IVF treatment to patients. The firm develops proprietary suite of patient communication tools. The company was founded by T. J. Farnsworth and is headquartered in Bellaire, TX.

Prothelia, Inc. operates as a biotechnological company that engages in the provision of protein therapy. It focuses on the treatment of congenital muscular dystrophy type 1A. The company was founded by Bradley Hodges and is headquartered in Milford, MA.

Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA.

Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation.